產品詳情
簡單介紹:
Anti-F7 antibody (240-400) (STJ118484)
詳情介紹:
Host: | Rabbit |
Applications: | WB |
Reactivity: | Human/Mouse/Rat |
Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: | Rabbit polyclonal antibody anti-F7 (240-400) is suitable for use in Western Blot research applications. |
Clonality: | Polyclonal |
Conjugation: | Unconjugated |
Isotype: | IgG |
Formulation: | PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: | Affinity purification |
Dilution Range: | WB 1:500-1:2000 |
Storage Instruction: | Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: | F7 |
Gene ID: | 2155 |
Uniprot ID: | FA7_HUMAN |
Immunogen Region: | 240-400 |
Immunogen: | Recombinant fusion protein containing a sequence corresponding to amino acids 240-400 of human F7 (NP_062562.1). |
Immunogen Sequence: | RNLIAVLGEHDLSEHDGDEQ SRRVAQVIIPSTYVPGTTNH DIALLRLHQPVVLTDHVVPL CLPERTFSERTLAFVRFSLV SGWGQLLDRGATALELMVLN VPRLMTQDCLQQSRKVGDSP NITEYMFCAGYSDGSKDSCK GDSGGPHATHYRGTWYLTGI V |
Tissue Specificity | Plasma. |
Post Translational Modifications | The vitamin K-dependent, enzymatic carboxylation of some glutamate residues allows the modified protein to bind calcium. The iron and 2-oxoglutarate dependent 3-hydroxylation of aspartate and asparagine is (R) stereospecific within EGF domains. O- and N-glycosylated. N-glycosylation at Asn-205 occurs cotranslationally and is mediated by STT3A-containing complexes, while glycosylation at Asn-382 is post-translational and is mediated STT3B-containing complexes before folding. O-fucosylated by POFUT1 on a conserved serine or threonine residue found in the consensus sequence C2-X(4,5)-S/T-C3 of EGF domains, where C2 and C3 are the second and third conserved cysteines. Can be either O-glucosylated or O-xylosylated at Ser-112 by POGLUT1 in vitro. |
Function | Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium. |
Protein Name | Coagulation Factor Vii Proconvertin Serum Prothrombin Conversion Accelerator Spca Eptacog Alfa Cleaved Into - Factor Vii Light Chain - Factor Vii Heavy Chain |
Database Links | Reactome: R-HSA-1368108 Reactome: R-HSA-140834 Reactome: R-HSA-159740 Reactome: R-HSA-159763 Reactome: R-HSA-159782 |
Cellular Localisation | Secreted |
Alternative Antibody Names | Anti-Coagulation Factor Vii antibody Anti-Proconvertin antibody Anti-Serum Prothrombin Conversion Accelerator antibody Anti-Spca antibody Anti-Eptacog Alfa Cleaved Into - Factor Vii Light Chain - Factor Vii Heavy Chain antibody Anti-F7 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
相關信息

- 細胞培養玄學-MRC-5細胞 2025-01-07
- Ocean NanoTech定製的詳細步驟 2021-10-31
- Abbiotec代理的產品得到重複驗證2020 2021-10-31
- LaysanBio代理商相關文獻資料2020 2021-10-31
- click chemistry tools數據結果比... 2021-10-31
- zyagen Laboratories代理的產品得到... 2021-06-20
- Toxin Technologies代理商相關文獻資... 2021-03-14
- 熱烈祝賀91麻豆福利视频网生物正式代理biocolor公司試劑產品... 2021-03-14
- 熱烈祝賀91麻豆福利视频网生物正式代理cytognos公司試劑產品... 2021-03-14
- Gelest代理的產品得到重複驗證2020 2021-03-14